The effects of St. John's wort on premenstrual syndrome in single women: A randomized double-blind, placebo-controlled study

Clinical Psychopharmacology and Neuroscience

Volumn 8, Issue 1, 2010, Pages 30-37

  Ryoo, Jung Gum ^a   Chun, Sae Il ^a   Lee, Young Jin ^a   Suh, Ho Suk ^a  

^a CHA University   (South Korea)

Author keywords

Beck depression inventory scale (BDI); Daily diary for PMS; Premenstrual assessment form (PAF); Premenstrual syndrome (PMS); Saint John's wort; Visual analogue scale (VAS)

Indexed keywords

HYPERICIN; HYPERICUM PERFORATUM EXTRACT; NON PRESCRIPTION DRUG; PARACETAMOL; PLACEBO;

ADULT; ANGER; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG HYPERSENSITIVITY; DYSPEPSIA; FEMALE; HOSTILITY; HUMAN; HYPERICUM PERFORATUM; IMPULSIVENESS; MENSTRUAL CYCLE; MENTAL INSTABILITY; NAUSEA; PAIN; PATIENT ASSESSMENT; PATIENT ATTITUDE; PREMENSTRUAL ASSESSMENT FORM; PREMENSTRUAL SYNDROME; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; SINGLE WOMAN; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 77952072349     PISSN: 17381088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Steiner M. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management. J Psychiatry Neurosci 2000;25:459-468. (Pubitemid 32059915)
2. Lee JY, Kang BJ. Ha JC. The Analysis of the Premenstrual Symptoms in Different Age Groups. J Korean Neuropsychiatr Assoc 1986;25:510-522.
3. Han SH, Hur MH. A study on the menstrual pain and dysmenorrhea, factors influenced to them, and self-management method for them of college students. J Korean Acad Soc Nurs Edu 1999;5:359-375.
4. Min AK. The effects of educational program for women with premenstrual syndrome. Korean J Women Health Nurs 1997;3:31-40.
5. Park YH, Jeong BS, Kim CY, Lee C. Prevalence of premenstrual dysphoric disorder and occupational function in a nurse group. J Korean Neuropsychiatr Assoc 2001;40:832-841.
6. Kim T. Medical treatment of premenstrual syndrome. J Korean Med Assoc 2005;48:672-678.
7. Kasper S, Gastpar M, Müller WE, Volz HP, Dienel A, Kieser M, et al. Efficacy of St. John's wort extract WS5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials. Eur Arch Psychiatry Clin Neurosci 2008;258:59-63.
8. Linde K, Berner M, Egger M, Mulrow C. St John's wort for depression: meta-analysis of randomised controlled trials. Br J Psychiatry 2005;186:99-107. (Pubitemid 40193777)
9. Williams JW Jr, Mulrow CD, Chiquette E, Nöel PH, Aquilar C, Cornell J. A systemic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med 2000;132:743-756. (Pubitemid 30244176)
10. Brenner R, Azbel V, Madhusoodanan S, Pawlowska M. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study. Clin Ther 2000;22:411-419.
11. Schrader E. Equivalence of St. John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild- moderate depression. Int Clin Psychopharmacol 2000;15:61-68.
12. Linde K, Knüppel L. Large-scale observational studies of hypericum extracts in patients with depressive disorders-a systematic review. Phytomedicine 2005;12:148-157. (Pubitemid 40174344)
13. Jun EM. A study on menstrual symptoms, coping and relief of symptoms in female college students. Korean J Women Health Nurs 2003;9:161-169.
14. Hicks SM, Walker AF, Gallagher J, Middleton RW, Wright J. The significance of "Nonsignificance" in randomized controlled stuidies: a discussion inspired by a double-blinded study on St. John's worts (Hypericum perforatum L.) for premenstrual symptoms. J Altem Complement Med 2004;10:925-932.
15. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 2002;136:42-53. (Pubitemid 35440247)
16. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory (BDI): twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100. (Pubitemid 18045797)
17. Rhee MK, Lee YH, Jung HY, Choi JH, Kim SH, Kim YK. et al. A standardization study of Beck Depression Inventory (II): Korean Version (K-BDI): Validity. Korean J Psychopathol 1995;4:96-104
18. Williams JG, Barlow DH, Agras WS. Behavioral measurement of severe depression. Arch Gen Psychiatry 1972;27:330-333.
19. Halbreich U, Endicott J, Schacht S, Nee J. The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form. Acta Psychiat Scand 1982;65:46-65. (Pubitemid 12179817)
20. Ko SG, Kwon JH. The effects of cognitive-behavioral group therapy for premenstrual syndrome. Cognitive Behavior Therapy in Korea 2004;4:1-11.
21. Koh Y, Joe SH, Kwak DI. Premenstrual Syndrome-Evaluated by premenstrual Assessment Form & Daily Rating Form-. J Korean Neuropsychiatr Assoc 1995:34:156-164.
22. Freeman EW, DeRubesis RJ, Rickels K. Reliability and validity of a daily diary of premenstrual syndrome. Psychiatry Res 1996;65:97-106. (Pubitemid 27052335)
23. Güzelcan Y, Scholte WF, Assies J, Becker HE. Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum). Ned Tijdschr Geneeskd 2001;145:1943-1945.
24. Fetrow CW, Avila JR. Professional's handbook of complementary and alternative medicine. 2nd edition. Lippincott Williams & Wilkins;2001. p.746-749.
25. Butterweck V. Mechanism of action of St John's wort in depression: what is known? CNS Drugs 2003;17:539-562.
26. Huang KL, Tsai SJ. St. John's wort (Hypericum perforatum) as a treatment for premenstrual dysphoric disorder: case report. Int J Psychiatry Med 2003;33:295-297.
27. Ernst E. Second thoughts about safety of St John's wort. Lanset 1999;354:2014-2016.
28. Barnes J, Anderson LA, Phillipson JD. St. John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 2001;53:583-600.
29. Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, et al. A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharmacol 2005;25:441-447. (Pubitemid 41368366)
30. Leucrubier Y, Clerc G, Didi R, Kieser M. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial Am J Psychiatry 2002;159:1361-1366. (Pubitemid 34832718)